Neodynamics
0.936 SEK +4.93%HC Andersen Capital receives payment from Neodynamics for a DigitalIR/Corporate Visibility agreement. See disclaimer.
7 investors are following this company
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Revenue
320K
EBIT %
-28,425 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
NEOD
Daily low / high price
0.874 / 0.938
SEK
Market cap
30.52M SEK
Turnover
4.06K SEK
Volume
4.5K
Analyst
Claus Thestrup
CEO, Sweden
Latest videos
Financial calendar
Interim report
2024-05-07
General meeting
2024-05-22
Interim report
2024-08-20
Interim report
2024-11-19
Annual report
2025-02-17
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Gryningskust Holding AB | 32.9 % | 32.9 % |
Rentability Sweden AB | 4.0 % | 4.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Salénterprise increases its shareholding in NeoDynamics.
NeoDynamics offentliggör slutligt utfall avseende nyttjande av teckningsoptionerna av serie TO3
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools